← Research library

[Impact of Bestim on the immunological status and clinical course of ulcer].

Observational study · 2004

What was studied
Patients receiving combined antiulcer treatment; sample size absent from abstract
Main finding
The report describes immune-marker changes, symptom regression and ulcer scarring with adjunctive Bestim.

Study data at a glance

Participants or experimental model
Patients receiving combined antiulcer treatment; sample size absent from abstract
Reported results
The report describes immune-marker changes, symptom regression and ulcer scarring with adjunctive Bestim.
Study limitations and source details

Study limitations

  • Sample size, comparator details and quantitative effects require the full report; this is not reliable evidence of standalone efficacy.
  • Full methods, reporting completeness and independent replication remain to be appraised.

Source details

Original journal report

Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.

Abstract reviewed

Sources checked

Citation

Uncontrolled human reportEnglish abstract

Tkacheva AG, Kalev OF, Dolgushina AI, Antipina TV. [Impact of Bestim on the immunological status and clinical course of ulcer]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology · PMID 16259438

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards